ClinicalTrials.Veeva

Menu

Expression of Tim-3 on Neutrophils in Ankylosing Spondylitis

A

Assiut University

Status

Begins enrollment in 3 months

Conditions

AS
Tim3
Ankylosing Spondylitis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

  1. To investigate the expression of Tim-3 on neutrophils in ankylosing spondylitis patients and its correlation with disease activity and inflammatory markers.
  2. Association of Tim-3 with sacroiliac MRI findings and the hip inflammatory MRI scoring system (HIMRISS) .

Enrollment

81 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Adult patients (>18 years) diagnosed as AS according to 2009 ASAS -Classification criteria (8) Exclusion Criteria:-Age below 18 years old. Patients with other autoimmune diseases. infection (cause increase in inflammatory makers) Any patient with ferromagnetic implants or cardiac pacemaker pregnancy Uncontrolled Hypertension renal failure Chronic liver disease Malignancy Diabetes Mellitus

Trial contacts and locations

1

Loading...

Central trial contact

Eman Safwat, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems